Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes
- PMID: 1732413
- PMCID: PMC2119116
- DOI: 10.1084/jem.175.2.481
Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes
Abstract
Cytotoxic T lymphocytes (CTL) recognize class I major histocompatibility complex molecules complexed to peptides of eight to nine residues generated from cytosolic proteins. We find that CTL recognize, in vitro and in vivo, cells synthesizing a 10-residue peptide consisting of an initiating methionine followed by nine residues corresponding to a naturally processed determinant from influenza virus nucleoprotein (NP) (residues 147-155). Addition of two COOH-terminal residues corresponding to NP residues 157 and 158 severely reduced presentation of the endogenously produced peptide to CTL in vitro and in vivo. Extension of NH2 and COOH terminal flanking residues to include residues corresponding to NP residues 137-146 and 159-168 failed to increase the antigenicity of this peptide. Its presentation was greatly enhanced, however, by further extending the NH2 and COOH termini to include all of the additional residues of NP. These findings indicate first, that a naturally processed viral ligand (with an NH2-terminal Met) of a class I molecule contains sufficient information to access intracellular class I molecules, and second, that flanking residues can influence the processing and presentation of antigens to CTL.
Similar articles
-
Influenza basic polymerase 2 peptides are recognized by influenza nucleoprotein-specific cytotoxic T lymphocytes.Mol Immunol. 1992 Sep;29(9):1089-96. doi: 10.1016/0161-5890(92)90041-u. Mol Immunol. 1992. PMID: 1495499
-
Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.J Immunol. 1992 Feb 1;148(3):894-9. J Immunol. 1992. PMID: 1370522
-
Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge.J Virol. 1994 Jun;68(6):3505-11. doi: 10.1128/JVI.68.6.3505-3511.1994. J Virol. 1994. PMID: 7514677 Free PMC article.
-
Cytotoxic T cells in influenza infection.Ann N Y Acad Sci. 1988;532:230-7. doi: 10.1111/j.1749-6632.1988.tb36342.x. Ann N Y Acad Sci. 1988. PMID: 2845845 Review. No abstract available.
-
Potential DNA vaccine integration into host cell genome.Ann N Y Acad Sci. 1995 Nov 27;772:30-9. doi: 10.1111/j.1749-6632.1995.tb44729.x. Ann N Y Acad Sci. 1995. PMID: 8546411 Review.
Cited by
-
The addition of recombinant vaccinia HER2/neu to oncolytic vaccinia-GMCSF given into the tumor microenvironment overcomes MDSC-mediated immune escape and systemic anergy.Cancer Gene Ther. 2015 Apr;22(3):154-62. doi: 10.1038/cgt.2015.2. Epub 2015 Jan 30. Cancer Gene Ther. 2015. PMID: 25633483 Free PMC article.
-
Evasion of influenza A viruses from innate and adaptive immune responses.Viruses. 2012 Sep;4(9):1438-76. doi: 10.3390/v4091438. Epub 2012 Sep 3. Viruses. 2012. PMID: 23170167 Free PMC article. Review.
-
Virus-induced diabetes in a transgenic model: role of cross-reacting viruses and quantitation of effector T cells needed to cause disease.J Virol. 2000 Apr;74(7):3284-92. doi: 10.1128/jvi.74.7.3284-3292.2000. J Virol. 2000. PMID: 10708445 Free PMC article.
-
Selection of virus variants and emergence of virus escape mutants after immunization with an epitope vaccine.J Virol. 1998 Feb;72(2):1403-10. doi: 10.1128/JVI.72.2.1403-1410.1998. J Virol. 1998. PMID: 9445041 Free PMC article.
-
Simian virus 40 T antigen as a carrier for the expression of cytotoxic T-lymphocyte recognition epitopes.J Virol. 1993 Nov;67(11):6866-71. doi: 10.1128/JVI.67.11.6866-6871.1993. J Virol. 1993. PMID: 7692088 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous